Udonitrectag (REC 0559), a low molecular weight compound that mimics NGF, aims to address the issue of NGF stability[1].
[1]. Levi N Kanu, et al. Nerve Growth Factor as an Ocular Therapy: Applications, Challenges, and Future Directions. Semin Ophthalmol. 2021 May 19;36(4):224-231.
















